CTOs on the Move

IconOVir

www.iconovir.com

 
IconOVir Bio is a preclinical-stage biotechnology company pioneering the next generation of oncolytic virus therapy to improve the treatment of patients with cancer. Our proprietary oncolytic virus platform is based on technology developed by scientific founder Clodagh O`Shea, Ph.D., of the Salk Institute. It is designed to address key limitations of first- and second-generation oncolytic viruses.
  • Number of Employees: 25-100
  • Annual Revenue: $1-10 Million
  • www.iconovir.com
  • 4570 Executive Drive Suite 350
    San Diego, CA USA 92121
  • Phone: n/a

Executives

Name Title Contact Details
John Huynh
 Chief Technology Officer Profile

Funding

IconOVir raised $77M on 01/05/2021

Similar Companies

EUSA Pharma Corporation

EUSA Pharma Corporation is a Princeton, NJ-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Delfi Diagnostics

Delfi is developing a new class of liquid biopsy tests for early detection based on altered genome-wide fragmentation profiles, also known as "fragmentomes," representing aberrant packaging of DNA in cancer cells. By applying advanced machine learning algorithms, these fragment patterns are detectable at a very low sequencing cost. Delfi is using this technology to develop highly sensitive and specific cancer detection assays intended for wide and cost-effective distribution and adoption.

GenVault Corporation

GenVault Corporation is a Carlsbad, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

www.velosbio.com

VelosBio, Inc. operates as a biotechnology firm specializing in oncology.

Planetrx Com

Planetrx Com is a South San Francisco, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.